INDV
NASD Indivior Pharmaceuticals, Inc.$36.06 ↑ +0.00 (+0.00%) Trading Up from the previous close of $36.06, $0.26 below the day’s high of $36.32
- YTD change
- +0.50%
- vs 20-day SMA
- +1.18%
- vs 200-day SMA
- +0.91%
Price ranges
Price & Performance
+4.46 (+14.11%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 15.8% away from all-time highs of $42.81
- INDV is up 1% since the beginning of the year
- INDV is up 52% over the past 12 months
- INDV is up 5% over the past 1 month
- 10% of all INDV investors are betting against INDV
INDV reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +51.1%.
- Previous minute
- +$0.00
- Last hour
- -$0.44
- Last 5 days
- +0.98%
- vs 8-day SMA
- +0.78%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
